Verona Emerges Victorious From Second COPD Trial

Ensifentrine Will Head To FDA In First Half Of 2023

 
• By Kevin Grogan
  
Neon Light Sign Lungs Icon
• Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Respiratory

More from Therapeutic Category